您的位置: 首页 > 农业专利 > 详情页

a novel compound having inhibitory angiogenesis activity, method for preparing same and pharmaceutical composition comprising the same
专利权人:
BORYUNG PHARMACEUTICAL CO.; LTD.
发明人:
HAHN-SUN JUNG,HEE JIN JEON,JE HAK KIM,JI HAN KIM,JOON KWANG LEE,KYUNG-TAE LEE,NAM SEOK HAN,SEUNG-HOON KANG,YONG PARK
申请号:
BR112014001963
公开号:
BR112014001963A2
申请日:
2012.07.27
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
Disclosed are an anti-angiogenic compound, represented by Chemical Formula I, or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutically acceptable composition including the same. Because the compound of Chemical Formular I potently suppresses the angiogenesis, the compound of Chemical Formula I is applicable to the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, and available as an anti-angiogenic agent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充